James P Harding

Title: Innovations of James P Harding

Introduction

James P Harding is a notable inventor based in Loudonville, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit Spleen Tyrosine Kinase. With a total of three patents to his name, Harding's work is influential in treating various medical conditions.

Latest Patents

One of Harding's latest patents includes the compound 6-(benzo[d]thiazol-5-yl)-N-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyrazin-8-amine. This patent provides imidazopyrazine compounds and methods for their use in inhibiting Spleen Tyrosine Kinase, which is crucial in treating conditions such as B-cell lymphomas, leukemias, and inflammatory disorders. Another patent focuses on certain imidazopyrazines that are effective in reducing signs or symptoms of diseases responsive to Syk activity inhibition. These innovations are vital for advancing therapeutic options in the medical field.

Career Highlights

James P Harding is currently associated with Gilead Connecticut, Inc., where he continues to innovate and develop new pharmaceutical solutions. His expertise in the field has led to the creation of valuable compounds that have the potential to improve patient outcomes.

Collaborations

Harding collaborates with esteemed colleagues such as Scott A Mitchell and Kevin S Currie. Their combined efforts contribute to the advancement of research and development in the pharmaceutical industry.

Conclusion

James P Harding's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work in developing compounds for treating serious medical conditions showcases the impact of his research on healthcare.